Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,375
Closed -$4.29M 175
2017
Q3
$4.29M Buy
1,375
+674
+96% +$12.8K 0.28% 44
2017
Q2
$1.2M Buy
701
+38
+6% +$649 0.08% 95
2017
Q1
$1.16M Sell
663
-796
-55% -$12.3K 0.06% 125
2016
Q4
$1.93M Hold
1,459
0.11% 105
2016
Q3
$2.12M Buy
1,459
+113
+8% +$1.42K 0.08% 127
2016
Q2
$1.33M Buy
1,346
+1,050
+355% +$12.3K 0.07% 139
2016
Q1
$375K Sell
296
-30
-9% -$394 0.02% 234
2015
Q4
$592K Sell
326
-185
-36% -$3.26K 0.03% 226
2015
Q3
$949K Buy
511
+185
+57% +$4.62K 0.04% 239
2015
Q2
$796K Hold
326
0.03% 230
2015
Q1
$678K Buy
326
+30
+10% +$529 0.03% 217
2014
Q4
$458 Buy
+296
New +$4.2K 0.01% 188
2014
Q3
Sell
-438
Closed -$873K 274
2014
Q2
$873K Sell
438
-864
-66% -$12.8K 0.04% 161
2014
Q1
$2.48M Sell
1,302
-689
-35% -$13.1K 0.14% 96
2013
Q4
$3.39M Buy
+1,991
New +$30.5K 0.22% 59
2013
Q3
Sell
-1,875
Closed -$2.24M 208
2013
Q2
$2.24M Buy
+1,875
New +$19.2K 0.15% 92

Other funds holding INSM

Sabby Management's INSM Position: Q4 2018 in Review

Sabby Management sold out of Insmed (INSM) in Q4 2018, closing a stake of 15,000 shares — an estimated $303K sold.

Sabby Management first reported a position in INSM in Q3 2014 and held it in 7 quarters. The position peaked at $636K in Q4 2016. 126 funds tracked by Wall St. Rank hold INSM as of Q4 2018.

  • Sabby Management reported no remaining Insmed position as of Q4 2018 after selling out during the quarter.
  • Sabby Management sold 15,000 Insmed shares in Q4 2018, an estimated $303K.
  • Sabby Management first reported a position in Insmed in Q3 2014 and held it in 7 quarters.
  • Sabby Management's Insmed position peaked at $636K in Q4 2016.
  • 126 funds tracked by Wall St. Rank held Insmed as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.